Citadel Advisors »

Reshape Lifesciences shares owned by Citadel Advisors

Quarter-by-quarter ownership of Reshape Lifesciences (RSLS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Reshape Lifesciences

Tip: Access up to 7 years of quarterly data

All positions including Reshape Lifesciences held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reshape Lifesciences by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $18k 73k 0.25

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Reshape Lifesciences

Virtu Financial
Vanguard Group
Tower Research Capital
BlackRock
Millennium Management
Goldman Sachs Group
Jane Street
Geode Capital Management
Two Sigma Securities
XTX Topco
Qube Research & Technologies
Wells Fargo & Company
Cornerstone Planning Group
Advisor Group Holdings
Group One Trading

View all funds holding Reshape Lifesciences